12/29/2025
Cannabis compounds have shown promising results in slowing the growth of aggressive ovarian cancer cells in laboratory tests. According to ScienceDaily, researchers found that CBD and THC, when used together, significantly inhibited cancer cell growth, reduced colony formation and blocked the cancer’s ability to spread. Importantly, the treatment caused minimal harm to healthy cells, suggesting that these compounds could one day be developed into safer therapies.
According to SciTectDaily, the compounds worked best in combination, particularly at a one to one ratio. They attacked cancer cells through several pathways including cell cycle arrest, programmed cell death and energy disruption. Remarkably, they were effective against both platinum sensitive and platinum resistant ovarian cancer cell lines, which are often difficult to treat with existing therapies.
While these findings are encouraging, researchers emphasize that the results are limited to laboratory studies. Animal testing and clinical trials are still needed before cannabis compounds can be considered safe and effective treatments for ovarian cancer in humans. This breakthrough highlights the potential of cannabinoids in cancer research but also the importance of careful testing before they can be used in medical practice.
